205 related articles for article (PubMed ID: 37934757)
21. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
[TBL] [Abstract][Full Text] [Related]
22. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
[TBL] [Abstract][Full Text] [Related]
23. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism.
Meads MB; Medveczky PG
J Biol Chem; 2004 Dec; 279(50):51793-803. PubMed ID: 15258150
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas.
Chen J; Wang Z; Phuc T; Xu Z; Yang D; Chen Z; Lin Z; Kendrick S; Dai L; Li HY; Qin Z
PLoS Pathog; 2023 Jan; 19(1):e1011089. PubMed ID: 36638143
[TBL] [Abstract][Full Text] [Related]
26. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways.
Osborne J; Moore PS; Chang Y
Hum Immunol; 1999 Oct; 60(10):921-7. PubMed ID: 10566591
[TBL] [Abstract][Full Text] [Related]
27. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
Khan YM; Kirkham P; Barnes PJ; Adcock IM
PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
[TBL] [Abstract][Full Text] [Related]
28. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit.
Molden J; Chang Y; You Y; Moore PS; Goldsmith MA
J Biol Chem; 1997 Aug; 272(31):19625-31. PubMed ID: 9235971
[TBL] [Abstract][Full Text] [Related]
29. KSHV vIL-6 promotes SIRT3-induced deacetylation of SERBP1 to inhibit ferroptosis and enhance cellular transformation by inducing lipoyltransferase 2 mRNA degradation.
Zhou J; Wang T; Zhang H; Liu J; Wei P; Xu R; Yan Q; Chen G; Li W; Gao SJ; Lu C
PLoS Pathog; 2024 Mar; 20(3):e1012082. PubMed ID: 38470932
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
[TBL] [Abstract][Full Text] [Related]
31. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
32. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.
He M; Zhang W; Bakken T; Schutten M; Toth Z; Jung JU; Gill P; Cannon M; Gao SJ
Cancer Res; 2012 Jul; 72(14):3582-92. PubMed ID: 22593192
[TBL] [Abstract][Full Text] [Related]
33. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.
Aoki Y; Yarchoan R; Wyvill K; Okamoto S; Little RF; Tosato G
Blood; 2001 Apr; 97(7):2173-6. PubMed ID: 11264189
[TBL] [Abstract][Full Text] [Related]
34. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.
Subramanian R; Sehgal I; D'Auvergne O; Kousoulas KG
J Virol; 2010 Feb; 84(4):1704-14. PubMed ID: 19955303
[TBL] [Abstract][Full Text] [Related]
37. The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation.
Chang PC; Cheng CY; Campbell M; Yang YC; Hsu HW; Chang TY; Chu CH; Lee YW; Hung CL; Lai SM; Tepper CG; Hsieh WP; Wang HW; Tang CY; Wang WC; Kung HJ
BMC Genomics; 2013 Nov; 14(1):824. PubMed ID: 24267727
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6.
Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC
J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression.
Kang JG; Pripuzova N; Majerciak V; Kruhlak M; Le SY; Zheng ZM
J Virol; 2011 Mar; 85(6):2620-30. PubMed ID: 21209110
[TBL] [Abstract][Full Text] [Related]
40. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
